Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

End-of-day quote. End-of-day quote  - 07/27
11.08 CAD   -1.25%
04:59p CARDIOME PHARMA : IIROC Trading Halt - COM
04:30p CARDIOME PHARMA : Announces Approximately US$15.0 Million Bought Dea..
04:10p IIROC Trade Halt - Cardiome Pharma Corp.
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
07/17/2015 07/20/2015 07/22/2015 07/24/2015 07/27/2015 Date
11.75 11.7 11.5 11.22 11.08 Last
2642 1046 2220 5430 1300 Volume
+3.25% -0.43% -1.71% -2.43% -1.25% Change
Financials ( CAD)
Sales 2015 41,3 M
EBIT 2015 -14,1 M
Net income 2015 -8,74 M
Debt 2015 -
Yield 2015 -
Sales 2016 52,0 M
EBIT 2016 -10,7 M
Net income 2016 0,53 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 4,50x
Capi. / Sales 2016 3,57x
Capitalization 186 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS,... 
Sector
Pharmaceuticals
Calendar
08/10Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
04:59p CARDIOME PHARMA : IIROC Trading Halt - COM
04:30p CARDIOME PHARMA : Announces Approximately US$15.0 Million Bought Deal Financing
04:10p IIROC Trade Halt - Cardiome Pharma Corp.
08:01a CARDIOME PHARMA : to Hold Second Quarter 2015 Financial Results Conference Call ..
07/27 CARDIOME PHARMA : Partner Eddingpharm To Initiate Brinavess Phase I Study In Chi..
07/24 CARDIOME PHARMA : Partner Eddingpharm to Initiate BRINAVESS Phase I Study in Chi..
07/22 CARDIOME PHARMA : Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT ..
06/29 CARDIOME PHARMA : SteadyMed and Cardiome Enter into a License Agreement for the ..
More news
Sector news : Biopharmaceuticals
05:47p AMGEN : Announces 2015 Third Quarter Dividend
05:42p JOHNSON & JOHNSON : Engaging the Workforce in Innovation Initiatives: An Intervi..
05:15pDJExpress Scripts Raises Guidance as Earnings Top Views
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/26 WEEK IN REVIEW : 3SBio Acquires Wansheng Pharma For $85 Million
05/13 Cardiome Pharma's (CRME) CEO William Hunter on Q1 2015 Results - Earnings Cal..
05/13 Cardiome Pharma reports Q1 results
05/13 Cardiome Pharma beats by $0.07, misses on revenue
05/12 Notable earnings before Wednesday's open


Comments 
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions